Table 2.
Outcomes of the included studies
| First author | Mortality | Survivors | Not discharged | Still on ECMO | Complications on ECMO | Days on ECMO* |
|---|---|---|---|---|---|---|
| Alnababteh | 6 | 4 | 3 | NR |
3 mechanical 7 haemorrhagic 6 renal 4 pulmonary 2 infectious 3 metabolic 2 limb |
12.85 ± 6.04 |
| Akhtar | 4 | 14 | 0 | 0 | 17.7 ± 9.4 | |
| Barbaro | 380 | 588 | 67 | 31 |
295 mechanical 69 neurologic 444 renal |
13.9 (7.8–23.3) |
| Charlton | 16 | 18 | 0 | 0 | ||
| Cousin | 16 | NR | NR | NR |
8 mechanical 27 haemorrhagic 4 neurologic 15 renal 2 pulmonary 4 infectious 3 limb |
10.67 ± 5.45 |
| Falcoz | 6 | 10 | 1 | 0 |
7 mechanical 62 haemorrhagic 1 neurologic 12 renal 1 cardiovascular 3 pulmonary 10 infectious 1 others (thrombocytopenia) |
9 [0–16] |
| Guihaire | 4 | 16 | 4 | 3 |
18 mechanical 1 neurologic 10 pulmonary 3 infectious 1 other (mesenteric ischemia) |
19.0 ± 10.1 |
| Huette | 4 | 8 | 0 | 0 |
5 mechanical 3 hemorrhagic 8 renal 1 cardiovascular 4 pulmonary 10 infectious 3 others (2 liver failure, 1 HIT) |
12 (9–22) |
| Jackel | 8 | 7 | 0 | 0 | ||
| Jang | 10 | 4 | 5 | 2 |
5 neurologic 9 renal 1 cardiovascular 6 pulmomary |
17.27 ± 16.42 |
| Jozwiak | 6 | 5 | 0 | 0 | ||
| Le Breton | 2 | 11 | 0 | 0 |
2 mechanical 3 hemorrhagic 2 infectious |
14.53 ± 8.84 |
| Masur | 5 | 1 | 6 | NR | 6 neurologic | 9.60 |
| Mustafa | 6 | 29 | 5 | 2 | 10 pulmonary | 29.9 ± 3.6 |
| Roedl | 13 | 7 | 0 | 0 | ||
| Schmidt | 25 | 38 | 20 | 5 |
25 mechanical 45 hemorrhagic 5 neurologic 38 renal 11 cardiovascular 50 pulmonary 129 infectious 7 others (5 thrombocytopenia, 2 HIT) |
20 (10–40) |
| Shih | 16 | 21 | 0 | 0 | ||
| Takeda | 67 | NR | 20 | 20 | NA | 14.42 ± 9.01 |
| Yang | 12 | 6 | 3 | 0 |
3 hemorrhagic 8 renal 8 cardiovascular 6 pulmonary 3 infectious |
NR |
| Zayat | 8 | 9 | 0 | 0 | ||
| Zeng | 5 | NR | 7 | 4 | NA | 11.3 ± 7.8 |
| Zhang | 14 | 29 | 0 | 0 |
ECMO, extracorporeal membrane oxygenation; NR, not reported
*Days on ECMO reported as mean ± SD, median (interquartile range) or median [range]